Michał Springer

2PUBLICATIONS
1CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 02, 2025
Efficacy and safety of CT-P39, an omalizumab biosimilar, in chronic spontaneous urticaria: 16-week follow-up study.

|Jan 17, 2024
Interleukin-6 Family of Cytokines in Cancers.

Iwona Zaporowska-Stachowiak, Michał Springer, Katarzyna Stachowiak

Pageof 1

Frequent Collaborators

1 joint publications

Sarbjit S Saini